Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

February 10, 2024 8:48 (London Time)

Guardant Health

Youtube Subscribe

...

Sector: Health Care Providers & Services
Ticker: GH
Sentiment: 0.4576
MarketCap: 2,717,691,169.0
High: 22.89 Low: 22.2

Open: 22.53 Close: 22.61 Change: 0.08

8 risks of investing in Guardant Health Stock found by an AI after reading the whole internet.

Are looking for the most relevant information about Guardant Health? Investor spend a lot of time searching for information to make investment decisions in Guardant Health. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Guardant Health are: Guardant, Health, company, share, stock, analysis, GH, and the most common words in the summary are: health, job, guardant, service, news, test, research, . One of the sentences in the summary was: Co-CEO AmirAli Talasaz recently sat down with Medium s Authority Magazine …

Concept Map

...

Semantic Network

...

Stock Summary

Guardant Health Inc. is a member of the Zacks.com (Strong Buy) list of Zacks. The consensus EPS estimate for the quarter has been revised 1.3%. Guardant Healthcare Inc has gained 4.83%.

Today's Summary

Guardant Health is a leading precision medicine company focused on guarding every person from cancer. Co-CEO AmirAli Talasaz recently sat down with Medium s Authority Magazine to share five insights everyone needs to know about cancer.

Today's News

Guardant Health, Inc. (gh) statistics & valuation metrics - stock analysis. guardant health, inc. (GH) Statistics & Valuation Metrics - Stock Analysis. - Stock analysis. Log in to save this job. Guardant Health is a leading precision medicine company focused on guarding every person from cancer. The company has a market cap of $2.74 billion and is 3557th most valuable company by market cap according to our data. Co-CEO AmirAli Talasaz recently sat down with Medium s Authority Magazine to share five insights everyone needs to know about cancer. Guardant Health is a specialist in reading blood ctDNA to profile tumors and recommend treatments. Guardant Health (GH) reported earnings of -$0.73 per share, beating the Zacks Consensus Estimate of $-0.93 per share. The plasmaMATCH trial is funded by Cancer Research UK. Guardant Health provides 4 weeks of paternity leave, supporting new fathers in the workforce. Employee stock purchase program (ESPP) allows contributions up to 10% of the base salary. Flexible PTO policy includes vacation and personal days.

Stock Profile

" Guardant Health Inc. is a member of the Zacks.com (Strong Buy) list of Zacks. The consensus EPS estimate for the quarter has been revised 1.3%. Guardant Health ( NASDAQ:GH – Get Free Report ) last announced its quarterly earnings data on Thursday, August 3rd. Guardant health had a negative return on equity of 427.89% and a negative net margin of 99.62% Guardant has a Bullish sentiment reading. Guardant Healthcare Inc has gained 4.83% while the S&P 500 has fallen -0.12% on the stock sell has FinerawdownloadRocket Blu DUPbangLearnemis � incons Guardant Health ( NASDAQ:GH – Get Free Report ) last posted its earnings results on Thursday, August 3rd. There are 117.69 M shares outstanding in Guardant Health Inc Registered Shs, which values the company at $3.45 B. Compared to the closing price on Tuesday 10/03/2023 on NAS of $28.79, this is a drop of 0.00%. The high in the last 52 weeks of Guardant health stock was 62.63. Guardant Health has a market cap of $3.31 billion. As of October 2023 the market cap is the worlds 3066th most valuable company by market cap according to our data. Guardant is the 30th most valued company in the world. Guardant Health stock climbs following piper sandler sandler upgrade (gh) Share of Guardant shares were up 7% in afternoon trading following an upgrade by Piper Sandler. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. Guardant has commercially launched Guardant360®, Guardant 360 CDx, and GuardantINFINITY™ tests for advanced-stage cancer patients, and  Guardant Reveal™ for early-stage. Guardant Health is a leading precision medicine company focused on helping conquer cancer globally. The Guardant health screening portfolio aims to address the needs of individuals eligible for cancer screening. Reimbursement Specialist, Payment Posting (Hybrid, Onsite or Remote Options) Reimbundation Specialist, Client Services (Regional Supervisor) Guardant Health   Stanford, CA Full Time Job Description We are looking for a full-time Client Services Supervisor. Guardant Health CEO Helmy Eltoukhy: CancerMoonshot dream for colorectal cancer is for all patients to have access to life-saving technologies like blood-based screening that can help identify cancers at their earliest stages Guardant Health hosted the WRP4LC at its headquarters to observe Lung Cancer Awareness Month. Guardant Health announces collaboration with Amgen to develop cancer-precision-oncology platform. The potential to target KRAS G12C represents a potentially major therapeutic advancement. Guardant Health CEO Helmy Eltoukhy: By 2030, #ColorectalCancer is projected to be the No. 1 cancer. GuardantINFINITY is a smart liquid biopsy that allows researchers to gain unprecedented insights."

Keywords

The game is changing. There is a new strategy to evaluate Guardant Health fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Guardant Health are: Guardant, Health, company, share, stock, analysis, GH, and the most common words in the summary are: health, job, guardant, service, news, test, research, . One of the sentences in the summary was: Co-CEO AmirAli Talasaz recently sat down with Medium s Authority Magazine to share five insights everyone needs to know about cancer.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #health #job #guardant #service #news #test #research.

Read more →

Related Results

...
March 14, 2024 23:35 (London Time)

Guardant Health

Guardant Healths Shield test was able to detect cancer with 83% sensitivity. Food and Drug Administration is expected to consider the Shield blood t…
Sector: Health Care Providers & Services
Ticker: GH
Sentiment: -0.9266
MarketCap: 2,313,758,883.0
High: 19.46 Low: 17.94

Open: 19.26 Close: 18.37 Change: -0.89

Read more →
...
February 10, 2024 8:48 (London Time)

Guardant Health

Guardant Health is a leading precision medicine company focused on guarding every person from cancer. Co-CEO AmirAli Talasaz recently sat down with …
Sector: Health Care Providers & Services
Ticker: GH
Sentiment: 0.4576
MarketCap: 2,717,691,169.0
High: 22.89 Low: 22.2

Open: 22.53 Close: 22.61 Change: 0.08

Read more →
...
October 04, 2023 19:04 (London Time)

Guardant Health

Guardant Health Inc. is a member of the Zacks.com (Strong Buy) list of Zacks. The consensus EPS estimate for the quarter has been revised 1.3%. Guar…
Sector: Health Care Providers & Services
Ticker: GH
Sentiment: 0.3582
MarketCap: 3,388,356,048.0
High: 29.11 Low: 27.64

Open: 28.79 Close: 27.69 Change: -1.1

Read more →
...
February 14, 2024 21:43 (London Time)

Guardant Health

Guardant Health is currently the 3589th most valuable company by market cap according to our data. The Payroll Specialist contributes to a world-cla…
Sector: Health Care Providers & Services
Ticker: GH
Sentiment: 0.9516
MarketCap: 2,589,028,702.0
High: 22.46 Low: 21.58

Open: 21.78 Close: 22.05 Change: 0.27

Read more →
...
January 14, 2024 12:21 (London Time)

Guardant Health

Guardant Health has struck a deal to promote its range of liquid and tissue biopsy tests for cancer screening across the Middle East and North Afric…
Sector: Health Care Providers & Services
Ticker: GH
Sentiment: -0.7595
MarketCap: 2,934,960,807.0
High: 25.66 Low: 23.93

Open: 25.18 Close: 24.2 Change: -0.98

Read more →